BCL6, a transcription repressor, plays an important role of initiation and maintenance of germinal center reactions [23, 24], which has been identified as one of predictors of outcome in several cancers, such as DLBCL and B-cell acute lymphoblastic leukemia (B-ALL) [25, 26]. This evidence concerns the gene BCL6 and B-cell acute lymphoblastic leukemia.